UBS analysts led by Eric Sheridan raised their price target on shares of Peloton from $85 to $58, but kept their ‘neutral’ rating on the stock. The firm sees Peloton as a business “that is poised to con’t to capitalize on shifting consumer behavior toward more in-home and health safety workout regimes.” The Final Round panel discusses the call.
